This is not the most recent version of the article. View current version (23 DEC 2013)

Intervention Review

Daclizumab for relapsing remitting multiple sclerosis

  1. Jia Liu1,*,
  2. Luning Wang1,
  3. Si-Yan Zhan2,
  4. Yinyin Xia3

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 18 APR 2012

Assessed as up-to-date: 13 FEB 2012

DOI: 10.1002/14651858.CD008127.pub3

How to Cite

Liu J, Wang L, Zhan SY, Xia Y. Daclizumab for relapsing remitting multiple sclerosis. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008127. DOI: 10.1002/14651858.CD008127.pub3.

Author Information

  1. 1

    Chinese PLA General Hospital, Department of Geriatric Neurology, Beijing, China

  2. 2

    School of Public Health, Peking University, Centre for Evidence Based Medicine and Clinical Research, Department of Epidemiology and Biostatistics, Beijing, China

  3. 3

    National Center for TB Control and Prevention, China CDC, Dept. of Surveilance and Statistics, Beijing, China

*Jia Liu, Department of Geriatric Neurology, Chinese PLA General Hospital, Fuxing Road 28, Beijing, 100853, China.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 18 APR 2012


This is not the most recent version of the article. View current version (23 DEC 2013)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.